Balance Sheets (USD $)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Current Assets:
Cash and cash equivalents	$ 96,324	$ 627,082
Accounts receivable, net of allowance for doubtful accounts of $182,880 in 2011 and $202,160 in 2010	1,154,459	796,221
Inventories	790,494	986,947
Advances to contract manufacturer	952,558	730,491
Prepaid expenses and other current assets	304,180	247,465
Total current assets	3,298,015	3,388,206
Accounts receivable-long term, net of allowance for doubtful accounts of $372,000 in 2011 and $438,840 in 2010	261,256	361,160
Advances to contract manufacturer	2,453,948	1,713,794
Investment in distributor, at cost	76,319	76,319
Investment in Medical Joint Venture	124,179	0
Furniture, Fixtures & Equipment net of accumulated depreciation of $446,484 as of December 31, 2011 and $426,482 as of December 31, 2010	52,309	66,936
Patents, net of accumulated amortization of $344,238 as of December 31, 2011 and $294,934 as of December 31, 2010	698,357	944,858
Other assets	27,819	57,750
Total assets	6,992,202	6,609,023
Current Liabilities:
Accounts payable -- short term	3,931,531	2,883,587
Accrued expenses and other payable	677,419	511,304
Total current liabilities	4,608,950	3,394,891
Long-term Liabilities:
Accounts payable -- long term	0	440,376
Notes payable-net of discount of $3,065 and $8,361, respectively	446,935	441,639
Total long-term liabilities	446,935	882,015
Commitments and Contingencies
Stockholders' Equity
Common stock, par value $.001; authorized 50,000,000 shares; 15,556,878 shares issued 1,501,457 shares to be issued and 15,523,545 shares outstanding as of December 31, 2011; 14,915,959 shares issued, 637,013 shares to be issued, and 14,882,626 shares outstanding as of December 31, 2010	17,058	15,552
Additional paid-in capital	63,690,837	62,606,043
Accumulated deficit	(60,860,062)	(59,377,962)
Treasury stock, at cost, 33,333 shares	(911,516)	(911,516)
Total stockholders' equity	1,936,317	2,332,117
Total liabilities and stockholders' equity	$ 6,992,202	$ 6,609,023